These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
164 related items for PubMed ID: 38627147
1. Antibody kinetics between birth and three months of life in healthy infants with natural exposure to Group B streptococcus: A UK cohort study. Karampatsas K, Hall T, Voysey M, Carreras-Abad C, Cochet M, Ramkhelawon L, Peregrine E, Andrews N, Heath PT, Le Doare K. Vaccine; 2024 May 10; 42(13):3230-3238. PubMed ID: 38627147 [Abstract] [Full Text] [Related]
3. Association between anti-capsular IgG levels at birth and risk of invasive group B streptococcus disease in Finnish newborns: a retrospective case-control study. Saukkoriipi A, Silmon de Monerri NC, Toropainen M, Lindholm L, Veijola R, Toppari J, Knip M, Radley D, Gomme E, Jongihlati B, Anderson AS, Palmu AA, Simon R. Lancet Microbe; 2024 Jul 10; 5(7):689-696. PubMed ID: 38679040 [Abstract] [Full Text] [Related]
5. The Protective Value of Maternal Group B Streptococcus Antibodies: Quantitative and Functional Analysis of Naturally Acquired Responses to Capsular Polysaccharides and Pilus Proteins in European Maternal Sera. Fabbrini M, Rigat F, Rinaudo CD, Passalaqua I, Khacheh S, Creti R, Baldassarri L, Carboni F, Anderloni G, Rosini R, Maione D, Grandi G, Telford JL, Margarit I. Clin Infect Dis; 2016 Sep 15; 63(6):746-753. PubMed ID: 27402816 [Abstract] [Full Text] [Related]
6. Natural acquired humoral immunity against serotype-specific group B Streptococcus rectovaginal colonization acquisition in pregnant women. Kwatra G, Adrian PV, Shiri T, Buchmann EJ, Cutland CL, Madhi SA. Clin Microbiol Infect; 2015 Jun 15; 21(6):568.e13-21. PubMed ID: 25680313 [Abstract] [Full Text] [Related]
10. Level of maternal antibody required to protect neonates against early-onset disease caused by group B Streptococcus type Ia: a multicenter, seroepidemiology study. Lin FY, Philips JB, Azimi PH, Weisman LE, Clark P, Rhoads GG, Regan J, Concepcion NF, Frasch CE, Troendle J, Brenner RA, Gray BM, Bhushan R, Fitzgerald G, Moyer P, Clemens JD. J Infect Dis; 2001 Oct 15; 184(8):1022-8. PubMed ID: 11574917 [Abstract] [Full Text] [Related]
11. Safety and immunogenicity of an investigational maternal trivalent group B streptococcus vaccine in healthy women and their infants: a randomised phase 1b/2 trial. Madhi SA, Cutland CL, Jose L, Koen A, Govender N, Wittke F, Olugbosi M, Meulen AS, Baker S, Dull PM, Narasimhan V, Slobod K. Lancet Infect Dis; 2016 Aug 15; 16(8):923-34. PubMed ID: 27139805 [Abstract] [Full Text] [Related]
16. Potential for Maternally Administered Vaccine for Infant Group B Streptococcus. Madhi SA, Anderson AS, Absalon J, Radley D, Simon R, Jongihlati B, Strehlau R, van Niekerk AM, Izu A, Naidoo N, Kwatra G, Ramsamy Y, Said M, Jones S, Jose L, Fairlie L, Barnabas SL, Newton R, Munson S, Jefferies Z, Pavliakova D, Silmon de Monerri NC, Gomme E, Perez JL, Scott DA, Gruber WC, Jansen KU. N Engl J Med; 2023 Jul 20; 389(3):215-227. PubMed ID: 37467497 [Abstract] [Full Text] [Related]
17. Serum, breast milk, and infant antibody after maternal immunisation with pneumococcal vaccine. Shahid NS, Steinhoff MC, Hoque SS, Begum T, Thompson C, Siber GR. Lancet; 1995 Nov 11; 346(8985):1252-7. PubMed ID: 7475716 [Abstract] [Full Text] [Related]